At least three different p30 forms which vary in isoelectric point (pI) were previously shown by two-dimensional (2D) gel electrophoresis to be present in purified virions obtained from several strains of murine leukaemia virus (MLV). This heterogeneity which had been identified by Coomassie Brilliant Blue staining has been further characterized by immunological techniques. Using as substrates two Moloney (M) MLV chronically infected cell lines (MJD-54 and clone 2 cells), we found that (i) all p30s had the antigenicity of M-MLV p30, when analysed by immunoblotting of virion proteins with anti-p30 sera, and (it) when cells were labelled with [35S]methionine, a ~4C-amino acid mixture, or [J~C]serine and lysates of purified virions were immunoprecipitated with goat anti-p30 sera, four p30 spots (pI 6.0, 6-1, 6.3 and 6.6) could be clearly identified. These results strongly support the viral origin of the heterogeneous p30 spots. We next examined infected cell lysates in an attempt to pinpoint the molecular basis of this heterogeneity. When we immunoprecipitated p30s from labelled cell lysates utilizing goat anti-p30 sera it was observed that (i) in contrast to the four virion p30s, there were only three intracellular p30s (pI 6.0, 6-3 and 6.6), (it) there was a threefold greater amount of the intracellular compared to the virion form of p30 with pI 6.0, (iii) tryptic peptide maps of both virion and intracellular p30s labelled either with pSS]methionine or 12Sl showed basically similar patterns with only slight differences in intensity among certain peptides for the p30s with pI 6.1, 6.3 and 6.6, and (iv) the intracellular p30 with pI 6.0 had a peptide that was not present in any of the other p30s. These results suggest that due to some as yet uncharacterized modification(s) of p30 and/or some structural differences between different p30s, a heterogeneity in pI exists. This may be important for assembly of the virion capsid. However, it is also possible that the p30 heterogeneity reflects the presence of multiple M-MLV proviruses within each of the infected cell clones.
INTRODUCTION
The internal structural proteins of routine leukaemia viruses (MLV) are encoded by the group-specific antigen (gag) gene and are synthesized as a 65 000 tool. wt. precursor polyprotein, termed Pr65 a°a. In trying to understand how MLV particles are assembled, we and others have focused on the processing of Pr650~. Pr65g°a is not glycosylated, although two covalent modifications, phosphorylation of the p12 domain (Naso et al., 1979) and myristylation of the p15 domain (Henderson et at., 1983 ; Schultz & Oroszlan, 1983 ) are known to occur. After these modifications, approximately 2000 Pr65s °a molecules are then assembled together with two RNA genomic molecules at the plasma membrane into a budding or nascent 'immature' particle. At some time during or after budding, Pr65ooa is proteolytically cleaved into the final four gag products: p30, the major capsid protein; p15, a hydrophobic membrane-associated protein; p 12 and p l0, two nucleic acid-associated proteins (van Zaane et al., 1976; Arcement et al., 1976; Yoshinaka & Luftig, 1977; Eisenman & Vogt, 1978 ). An interesting problem that still remains concerning assembly is how the icosahedral virus capsid is constructed from only one species of polypeptide, i.e. p30, which is used both at vertices (fivefold symmetry axis) as well as on the surface of the capsid shell (two-and threefold symmetry axes).
For polyoma virus, multiply charged forms of VP1, the major virus capsid protein, exist (Bolen et al., 1981) . Recently, it was found that the two most acidic forms of VP1, out of at least four subspecies, were phosphorylated. Further, the occurrence of this phosphorylation event is directly correlated with the ability of viruses to assemble (Garcea et al., 1985) . Multiple forms of the MLV capsid protein p30 have also been shown to exist in virions when they were analysed by two-dimensional (2D) gel electrophoresis (Ledbetter, 1979; Wolfe et al., 1984) . In further studies it was found that the pI heterogeneity seen for MLV p30s was not an artefact of the 2D gel technique, since the same heterogeneity could be detected by chromatofocusing, another technique that utilizes non-denaturing protein separation conditions (Katoh et al., 1984) . We wondered whether the variety of MLV p30 species might, like that of VP1 in polyoma virus, ensure that an icosahedral capsid shell can be assembled from a single polypeptide species. Therefore we have further characterized the pI heterogeneity of Moloney (M) MLV p30 by serological techniques, compared the virion and intracellular forms of M-MLV p30, and analysed each of the p30 spots by tryptic peptide mapping methods.
METHODS
Viruses and cells. MJD-54 cells are a line of JLS-V9 mouse fibroblasts chronically infected with M-MLV. They were used in early (passage 24) as well as later passages with the same results. Clone 2 cells are a cloned cell line of 3T3 mouse fibroblasts chronically infected with M-MLV. These cell lines were obtained from Dr K. Manly (Roswell Park Memorial Institute, Buffalo, N.Y., U.S.A.). SC-1 cells are uninfected mouse fibroblasts (Hartley & Rowe, 1975) obtained from Dr M. Dewey (University of South Carolina, Columbia, S.C., U.S.A.). All cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5 ~ newborn calf serum.
Cell cloning. MJD-54 and clone 2 cells were seeded in 96-well microtitre plates (Costar) at an average of 1 living cell/well (cell viability was determined by trypan blue staining). The cells in each well containing a single clone were then transferred to dishes (35 mm diam. ; Costar), grown to a monolayer and cloned again. After being cloned three times, the cells were grown and used as a clone or subclone of the original parental cell line.
Radiolabelling of cells.
Cells were grown to confluence in 60 mm diam. dishes (Costar) in DMEM supplemented with 10~ newborn calf serum. The monolayer cell growth medium was then replaced with new medium containing DMEM supplemented with 2 % newborn calf serum every day for 2 days. Then these cells were labelled in one of three ways: (i) for 16 h with [35S]methionine (1125 Ci/mmol; New England Nuclear) in 2 ml/dish of MEM containing one-tenth the normal concentration of methionine and 4~o foetal calf serum, (ii) with a 14C-amino acid mixture (55.0 mCi/matom carbon; New England Nuclear) in 2 ml/dish of MEM containing one-tenth the normal concentration of amino acids and 4 ~o foetal calf serum, or (iii) with [14C]serine (169.0 mCi/mmol; New England Nuclear) in 2 ml/dish of MEM containing 4~ foetal calf serum. In short-term labelling experiments, cells were starved for 1 h in methionine-free MEM, and labelled with [35S]methionine in 2 ml/dish of methionine-free MEM for 2 h. For pulse-chase experiments, cells were also starved for 1 h, pulse-labelled with [35S]methionine in 1 ml/dish of methionine-free MEM for 15 min, and then chased for 15 min, 1 h and 4 h in 1 ml/dish of DMEM containing 5~ foetal calf serum and a tenfold excess of L-methionine.
Immunopreeipitation. Radioactive virion fractions were obtained from the culture fluids of labelled cells by centrifugation through 25~o (w/v) sucrose in 0.l M-NaC1, 0.01 M-Tris-HCI pH 7.4, 1 mM-EDTA and 1 mt, I-PMSF at 46000 r.p.m, in a SW50.1 rotor for 2 h at 4°C according to the method of Ro & Ghosh (1984) . For immunoprecipitation, detergent lysates of labelled cells or virus pellets were made by suspension in a buffer of 0.5~ NP40 and 0.5% sodium deoxycholate in TNE buffer (0.05 M-Tris-HC1 pH 7.2, 0.1 M-NaC1, 1 mM-EDTA containing 1 mM-PMSF). The lysates were then immunoprecipitated with a goat antiserum, anti-Rauscher MLV p30 (lot 78S-221), obtained through the Resources Program of the National Cancer Institute. The immune complexes were then precipitated with Protein A-Sepharose CL-4B (Pharmacia) and extensively washed with 1 NP40 in TNE buffer.
2D gel eleetrophoresis.
Immunoprecipitates were analysed by 2D gel electrophoresis according to the method of O'Farrell (1975) and O'Farrell et al. (1977) with slight modifications. Briefly, the immunoprecipitates were suspended in 20 gl of I ~ SDS containing 100 mM-DL-dithiothreitol and kept for 1 h at room temperature, heated for 3 rain at 95 to 100 °C, and then treated with 10 ~tl of 0.1-~-N-ethylmaleimide as described previously (van Zaane et al., 1976) . After 1 h at 4 °C, 5 gl of 2-mercaptoethanol, 12 gl of Ampholines (13.3 ~ Ampholines pH 5 to 8, and 3.3~ Ampholines pH 3.5 to 10; LKB), 10 ~tl of20~ NP40 and 60 mg solid urea were added, and the samples were separated according to charge by linear non-equilibrium pH gradient electrophoresis (NEPHGE) using 1.6~
Ampholines pH 5 to 8, and 0.4~ Ampholines pH 3.5 to 10 as described previously (Ikuta et al., 1983) .
Electrophoresis was carried out for 15 h at 300 V and 1 h at 800 V. After NEPHGE, the pH gradient of each gel was directly measured by using a miniature electrode (Gel Pro-pHiler; Bio-Rad) at 0.5 cm intervals along the gel length. Then, the gels were equilibrated in SDS-PAGE sample buffer (2-3~ SDS, 5~ 2-mercaptoethanol, 10~ glycerol, 62.5 mi-Tris-HC1 pH 6.8) and subjected to electrophoresis in the second dimension (separation gel, 6 to 12 ~ linear gradient polyacrylamide gel; spacer gel, 4 ~ gel) under the conditions of SDS-PAGE according to the method of Laemmli (1970) . Fluorograms were prepared by the method of Chamberlain (1979) .
Immunobloning analysis. Viruses were partially purified from the culture fluids of MJD-54 and clone 2 cells by initial treatment with polyethylene glycol 6000 at 8-5 ~ in the presence of NaC1 at a final concentration of 0.4 (Aboud et al., 1982) ; then precipitates were loaded onto a 20 to 50 ~ (w/v) linear sucrose gradient in 0.1 M-NaCI, 0"01 M-Tris-HC1 pH 7.4, 1 mM-EDTA and centrifuged at 35000 r.p.m, for 1 h in a Beckman SW41 rotor. The virus band obtained was then diluted into the same buffer as the gradient and centrifuged at 40000 r.p.m, for 30 rain in a SW50.1 rotor. The pellet was solubilized in 1 ~ SDS containing 100 mM-DL-dithiothreitol and separated by 2D gel electrophoresis as described above. Polypeptides in the gel were transferred onto nitrocellulose (Bio-Rad) according to the method of Towbin et al. (1979) . The nitrocellulose was treated with 20~ bovine calf serum in phosphate-buffered saline (PBS) for 1 h at room temperature to reduce non-specific binding and then reacted with goat anti-p30 overnight at 4 °C. After being washed with PBS, the nitrocellulose was incubated with horseradish peroxidase-conjugated rabbit anti-goat IgG (heavy and light chain-specific; Cappel Laboratories) for 1 h at room temperature. After washing with PBS, the nitrocellulose was then reacted with o-dianisidine in 10 mi-Tris-HCl pH 7.4.
Tryptic peptide analysis. Radioactive proteins were separated by 2D gel electrophoresis as described above, and each p30 spot which differed in pI was identified by fluorography and sliced out of the gel. For 125i_chloramine_ T labelling of tyrosine-containing tryptic peptides, polypeptides were iodinated in the gel slice with 125I (ICN) using the method of Elder et al. (1977) . Both iodinated p30 gel slices and p30 gel slices obtained after cells had been labelled with [~sS]methionine were extensively washed with l 0~ methanol, and then incubated at 37 °C overnight with 0-5 ml of 50 ~tg/ml of TPCK-trypsin (Worthington) in 0.05 M-NH4HCO3 buffer pH 8.0. The supernatants were removed and lyophilized. The samples were then analysed on cellulose-coated thin-layer chromatography plates (20 × 20 cm; Eastman Kodak). The samples were first analysed by electrophoresis in Buffer I (acetic acid : formic acid : water, 15 : 5 : 80), and secondly by ascending chromatography in Buffer II (butanol : pyridine : acetic acid:water, 32.5:25:5:20) as described by Elder et al. (1977) .
RESULTS
Our previous studies on the heterogeneity in pI of MLV p30 obtained from several different strains showed that it was real and not due to an artefact of the urea-containing buffer system used in 2D gel electrophoresis (Katoh et aL, 1984) . Specifically we showed that all of the MLV exhibited one major (70 to 90~ staining) p30 spot, as well as at least two minor spots, one more basic and one more acidic than the major spot. Since this heterogeneity in p! had only been observed by Coomassie Brilliant Blue staining, it was not clear whether the several forms of p30 seen by this technique were viral in origin nor whether they were due to a single virus species. Therefore, we examined the immunoreactivity of each of the heterogeneous p30 spots for M-MLV produced either by the high producer MJD-54 cells or a cloned line of cells, i.e. clone 2 cells.
Immunological reactivity of virion-associated p30s
In support of our initial observation (Katoh et al., 1984) , we show in the 2D gel pattern of Fig. 1 (a) that there were at least three p30 forms for virions which had been purified from the culture fluids of MJD-54 cells. The polypeptides exhibited a major p30 spot of pI 6.3 and two minor spots at pI 6.1 and 6.6. The former spot tended to be smeared because of the large amount of the nearby major spot. We performed this experiment (Fig. 1 ) because of two concerns expressed above: (i) because the MJD-54 cells, albeit used in early passage (no. 24) were still uncloned, it was possible that the p30 charge heterogeneity reflected a heterogeneity in the virus population, and (ii) it was possible that the minor p30 spot(s) were contaminating, non-viral proteins. The first possibility is unlikely because, as seen in Fig. 1 (c) , clone 2 cells produced virus particles which had a 2D gel MLV p30 pattern very similar if not identical to that of M-MLV from MJD-54 cells (Fig. 1 a) . The second possibility is also unlikely since immunoblotting of virion K. IKUTA AND R. B. LUFTIG polypeptides with goat anti-p30 serum ( Fig. 1 b and d) showed strong identity with the pattern obtained after Coomassie Brilliant Blue staining ( Fig. 1 a and c, respectively) . This result indicates that all three p30s had the antigenicity of MLV p30, since the anti-p30 serum was reacted with the p30 polypeptide only after it had been separated to its specific pI by 2D gel electrophoresis. Another way to determine the immunological identity of the heterogeneous p30 spots is by analysis of immunoprecipitates. MJD-54 and clone 2 cells were continuously labelled with [35S]methionine, 14C-amino acid mixture or [14C]serine for 16 h as described in the Methods section. These long-term radioactively labelled virions were next partially purified from the culture fluids by centrifuging through a 25 ~ (w/v) sucrose cushion. Virion lysates were prepared in lysis buffer, reacted with goat anti-p30 serum, and immunoprecipitates were analysed by 2D gel electrophoresis (Fig. 2) . At least four spots (pI 6.0, 6.1, 6.3 and 6.6) were clearly immunoprecipitated from [3SS]methionine-and 14C-amino acid mixture-labelled MJD-54 virion lysates (Fig. 2a and c) . A similar grouping of at least four spots was observed with labelled clone 2 virion lysates, although the separation here was clearest with the [~4C]serine-labelled lysate (Fig. 2f) . The pI 6-0 spot in Fig. 2 was not seen in Fig. 1 , presumably because of Coomassie Blue stain smearing. Unimmunized goat serum did not precipitate any of the above four p30 spots from virion lysates (data not shown). Thus, in confirmation of the immunoblotting experiment, virtually identical heterogeneous MLV-specific p30 patterns were found for virions produced by either MJD-54 or clone 2 cells. 
Immunological reactivity of intracellular p30s
We next examined the state of M L V p30s inside infected MJD-54 cells after a short pulse (15 min) of radioactive label, followed by a chase of 15 to 240 rain. As seen in Fig. 3 , when cell lysates in lysis buffer were reacted with goat anti-p30 serum and the immunoprecipitates were analysed on 2D gels, label was found in only two p30 spots at 15 m i n post-chase (Fig. 3 b) and in three spots, with pI 6.0, 6.3 and 6.6, at 60 or 240 min post-chase (Fig. 3c or d ), This contrasted with the p30 pattern seen in virions obtained from cells labelled under the same experimental conditions, where label was clearly present in a pI 6.1 spot by 60 m i n post-chase (Fig. 4c) . We also note from Fig. 3 (a) and (b) that cleavage of the intracellular Pr65g °g and Pr55g~ polyproteins at 0 and 15 m i n post-chase was correlated with the large increase of p30 label appearing in virions ( Fig. 4c and d) at 60 m i n and 240 m i n post-chase. The residual pool of p30 seen at these times in cells (Fig. 3 e and d) probably represented, in large part, cell-associated virions that were in vesicles and had not yet been released from cells. Fig. 6 . Comparison of the methionine-containing tryptic peptide maps among the four virion p30s. Virion fractions were prepared from culture fluids of clone 2 cells that had been labelled with [3sS]methionine for 16 h. The virion lysates were immunoprecipitated and separated as in Fig. 2 . After preparation of the fluorograms, the individual p30 spots with pI 6.0 (a), 6.1 (b), 6.3 (c) and 6.6 (d) were sliced from the gel, the slices were incubated with TPCK-trypsin overnight at 37 °C, and then the supernatants were analysed two-dimensionally on cellulose-coated thin-layer chromatography plates. The sample origin is circled. Samples were electrophoresed from top to bottom of figures and chromatographed from right to left. [As an aside, we note that due to the larger amount of radioactivity present in pl 6.3 (c) than the other p30 pls, there was apparently incomplete digestion of the p30 material, resulting in a series of spots near the origin. Digestion with an increased amount of trypsin for a longer period resulted in loss of these spots and increased density of the spots marked by the arrow (data not shown .3 (c) and 6.6 (d) and intracellular p30 spots with pI 6.0 (e), and 6.3 (f) in gel slices were prepared as described in Fig. 6 . The MJD-54 virion p30 with pI 6.3 was similarly prepared (g). The p30 polypeptides in the gel slices were radioiodinated. After being extensively washed with 10 ~ methanol, the iodinated p30s in gel slices were trypsinized, and analysed as in Fig. 6 . The spots common to all digests are represented diagrammatically in (h); an extra spot is indicated in (e).
Unexpectedly, the short-term labelling experiment showed an absence of intracellular MLV p30 with a pI of 6.1. It could also be seen (Fig. 3d and 4d ) by comparing the pI 6.0 spot at 4 h post-chase to the pI 6.3 spot that there was a greater (about threefold) amount of label in the intracellular p30 spot with pI of 6.0 (quantified by densitometry of the corresponding autoradiogram ; data not shown). No p30 spots were seen at all when uninfected SC-1 cell lysates were analysed similarly, and so the results reported above are specific for MLV p30.
To determine whether the intracellular p30 patterns were invariant for MLV-infected cells or were related to the use of a particular MLV-infected cell lysate, we cloned MJD-54 and subcloned clone 2 cells three times by the limiting dilution method and then labelled the cells with [35S]methionine for 2 h. The immunoprecipitates from these cell lysates with anti-p30 serum were separated by 2D gel electrophoresis (Fig. 5) . All of the cloned cells, four clones from MJD-54 cells and one subclone from clone 2 cells, showed a p30 pattern similar to that of the parental lines. There was also an approximately threefold increase in the amount of the intracellular pI 6.0 spot relative to that obtained for the pI 6.0 spot from corresponding virion lysates (data not shown).
Tryptic peptide analysis
To examine possible differences between the intracellular and virion pI 6.0 spots, and to determine the possible cellular origin of the virion pI 6.1 spot, we examined each p30 spot by tryptic peptide mapping. The p30 tryptic peptides were labelled by methods using [3SS]methionine or 125I (predominantly labelling exposed tyrosine residues on the MLV p30s). The patterns of the tryptic peptides containing [3SS]methionine in clone 2 virion p30s were virtually identical, showing two major peptides for the p30s with pI 6.0, 6.1, 6.3 and 6.6 (Fig. 6 ), indicating that no major structural change had occurred to alter the pIs. To increase the sensitivity of this method we used 1251 labelling of the p30 spots, which yielded approximately nine tryptic peptides (Fig. 7h) . Fig. 7 (a) to (d) represent the pattern of the clone 2 virion p30s of pI 6.0, 6.1, 6.3 and 6.6, respectively, and the panels (e) and (f) represent the patterns for clone 2 intracellular p30s of pI 6.0 and 6.3, respectively. Fig. 7 (g) is the pattern for MJD-54 virion p30 with pI 6.3. We deduce several points from this figure. (i) The patterns of 12SI-p30 tryptic peptides were very similar among the virion p30s ofpI 6.1 and 6.3 (b and c) while the patterns of the virion p30s with pI 6.0 and 6.6, although of lower intensity were similar to them in overall appearance (a and at). (ii) Comparison of virion p30 tryptic peptide maps (a to d) with intracellular p30 tryptic maps (e, f) showed that the intracellular p30 with pI 6.0 had one additional tryptic peptide (arrow in e), which could not be clearly identified in the corresponding virion p30 (a); this additional intracellular spot was seen both with MJD-54 and with clone 2 infected cell lysates. (iii) The virion and cellular p30s with pI of 6.3 (b,fand g) were very similar.
DISCUSSION
Multiple forms of p30 were first separated on 2D gels by Ledbetter (1979) . Thereafter, Katoh et aL (1984) dcmonstrated that the observed p30 heterogeneity in pI was not due to the denaturation of p30 by urea which was used in the first dimension of electrophoresis. In this report, we have further charactcrizcd this heterogeneity. We found that for M-MLV there are at least four clearly identifiable forms (pI 6.0, 6.1, 6.3 and 6.6) of p30 in purified virions as identified by immunoblotting of the 2D gels or immunoprecipitation of virion lysates with goat anti-p30 serum. These results strongly suggest that all four forms of p30 share at least one antigenic determinant.
The pattern seen on 2D gels of p30 immunoprecipitated from cell lysates was somewhat different to that seen in virion lysates using the serum. First, the p30 spot with pI 6.1 was clearly identified as a distinct spot in virions, but not in cells. This may mean it is not present in cell lysates and is formed in virions only after they have been released or that the goat anti-p30 serum does not recognizc it in cells because it has a different epitope. Secondly, the amount of intracellular p30 with pI 6.0 was about three times greater than the corresponding virion p30 of pI 6.0. This increase may be related to our observation that one of the tryptic peptides of intracellular p30 with pI 6.0 is not found in the virion p30 with pI 6.0.
Further, the observation that the predominant form of MLV p30 in virions is that with pI 6.3 and also that this is a major p30 form found inside cells, suggests that after cleavage of Pr65 ga° during or just after budding, it is probably the major form of p30 involved in formation of the icosahedral capsid. The nature of the heterogeneity in the other minor p30 species is not known. Thcy may be due to as yct uncharacterized post-translational modifications of the major p30 with pI 6.3 or thcy could bc derived from minor gag precursors such as PrlS0 ~ao-p°~ (Jamjoom et al., 1977; Kopchick et al., 1978 Kopchick et al., , 1979 or gPr800og (Ledbetter et al., 1978; Edwards & Fan, 1979; Lcdbetter, 1979) . It is of interest to note in this regard that thc usc of monoclonal antibodies to p30 suggests there arc at least three different p30 epitopes which can be identified (Chuat et al., 1985) . The use of such sera may assist us in identifying which, if any, of the gag precursors arc the source of the minor p30s.
To gain additional insight into the p30 pI heterogeneity, maps of tryptic peptides labelled with methionine or 12sI (presumably at tyrosines) were constructed for all MLV p30s. We could not identify great differences among the peptides; however, the virion p30s with pI 6.0 and 6-6 had a tyrosine-containing tryptic peptide map slightly different (in relative intensity of spots) to the two others, which were very similar to each other. It should be noted as wcll that we had previously observed five differences between thc tryptic peptide patterns of the two M-MLV p30s with pI 6.3 and 6.1 (Katoh et al., 1984) , when the p30s had been obtained from chromatofocusing columns prior to labelling with ~zsI. About 20 tryptic peptide spots were found then, whereas only 10 spots are reported in this study which utilized p30 from 2D gels for labelling with i ZSl. We believe that the most likely explanation for the difference in the results is that the earlier trypsin digestion (Katoh et al., 1984) was incomplete, causing variations in the intensity of peptide spots. However, since Katoh et al. (1984) used undenatured p30 substrates for digestion, in contrast to the p30 obtained from 2D gel spots, we still cannot rule out the possibility that the differences are real.
Finally, we note that there are further possible explanations for the M-MLV p30 heterogeneity other than that presented above. Specifically, since all the experiments were performed in mouse fibroblasts chronically infected with M-MLV, we may be observing multiple p30s arising from virus variants in multiply infected cells or the multiple p30s may reflect the expression of multiple MLV proviruses within each infected cell clone. We believe that these latter possibilities are less likely, since (i) the same heterogeneous pattern of virion p30s is observed with at least two different M-MLV isolates, namely from MJD-54 and clone 2 cells at both early and later passages, (ii) if endogenous virus products were being expressed, the p30s would have to be from a M-MLV specifically, rather than from an AKR or Rauscher MLV provirus, since the latter code for p30s with a different p30 pI pattern (Katoh et al., 1984) , and (iii) subclones of both MJD-54 and clone 2 infected cells provide essentially the same heterogeneous pattern of intracellular p30s. However, we still cannot rule out the alternative possibilities until we have looked for p30 heterogeneity in non-mouse, e.g. normal rat kidney, cells infected with a molecularly cloned M-MLV.
